2001
Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected with Mycobacterium tuberculosis
Sadaphal P, Astemborski J, Graham N, Sheely L, Bonds M, Madison A, Vlahov D, Thomas D, Sterling T. Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected with Mycobacterium tuberculosis. Clinical Infectious Diseases 2001, 33: 1687-1691. PMID: 11641824, PMCID: PMC2650436, DOI: 10.1086/323896.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersTuberculosis infectionValue elevationDrug usersCurrent injection drug useLatent Mycobacterium tuberculosis infectionHepatitis C virus infectionHepatitis B surface antigenLow HCV prevalenceC virus infectionIsoniazid preventive therapyInjection drug useM. tuberculosis infectionMycobacterium tuberculosis infectionHIV-1 infectionHuman immunodeficiency virusB surface antigenConcurrent alcohol useDrug discontinuationHCV prevalencePreventive therapyImmunodeficiency virusProspective studyTransaminase values
1995
Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland.
Gershon R, Vlahov D, Farzadegan H, Alter M. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infection Control And Hospital Epidemiology 1995, 16: 194-7. PMID: 7636165, DOI: 10.1086/647089.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis B virusHepatitis B vaccinationHepatitis C virusB vaccinationImmunodeficiency virusBloodborne pathogensB virusNon-occupational risk factorsHepatitis C virus infectionHepatitis B surface antigenHepatitis B surface antibodyBloodborne pathogen infectionsC virus infectionDoses of vaccineHepatitis B vaccineB surface antigenMarker of protectionB surface antibodyAdequate titersBloodborne exposuresHBV infectionHCV infectionB vaccineHIV infectionOccupational Risk of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Funeral Service Practitioners in Maryland
Gershon R, Vlahov D, Farzadegan H, Alter M. Occupational Risk of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Funeral Service Practitioners in Maryland. Infection Control And Hospital Epidemiology 1995, 16: 194-197. DOI: 10.2307/30140977.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis B virusHepatitis B vaccinationHepatitis C virusB vaccinationImmunodeficiency virusBloodborne pathogensB virusNon-occupational risk factorsHepatitis C virus infectionHepatitis B surface antigenHepatitis B surface antibodyBloodborne pathogen infectionsC virus infectionDoses of vaccineHepatitis B vaccineB surface antigenMarker of protectionB surface antibodyAdequate titersBloodborne exposuresHBV infectionHCV infectionB vaccineHIV infection